Nuvation Bio Inc (NUVB) — Cash Flow Reinvestment Rate
Latest as of March 2026:
8.61x
Nuvation Bio Inc (NUVB) has a Cash Flow Reinvestment Rate of 8.61x as of March 2026, reinvesting $43.64 Million (capex $48.00K plus investments $-43.59 Million) from operating cash flow of $5.07 Million. Check cash flow quality index of Nuvation Bio Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
8.61x
(Capex + Investments) / Operating CF
Total Reinvested
$43.64 Million
Capex + Investments
Operating Cash Flow
$5.07 Million
USD
Capital Expenditures
$48.00K
USD
Annual Cash Flow Reinvestment Rate for Nuvation Bio Inc (None–None)
Year-by-year capital reinvestment analysis for Nuvation Bio Inc. For live market cap and broader valuation context, see Nuvation Bio Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow